Preferred Label : Levodopa;
NCIt synonyms : (--)-3-(3,4-Dihydroxyphenyl)-L-alanine; beta-(3,4-Dihydroxyphenyl)-L-alanine; (--)-2Amino-3-(3,4-dihydroxyphenyl)propanoic Acid;
NCIt related terms : 3-Hydroxy-L-tyrosine; Dopasol; Eldopar; (-)-3-(3,4-Dihydroxyphenyl)-L-alanine; L-DOPA; 3-(3,4-Dihydroxyphenyl)-L-alanine; Bendopa; Dopalina; Dopar; Levopa; Deadopa; Cidandopa; L(-)-Dopa; Dopaidan; Larodopa; Maipedopa; Eldopal; .beta.-(3,4-Dihydroxyphenyl)-L-alanine; L-.beta.-(3,4-Dihydroxyphenyl)alanine;
NCIt definition : An amino acid precursor of dopamine with antiparkinsonian properties. Levodopa is
a prodrug that is converted to dopamine by DOPA decarboxylase and can cross the blood-brain
barrier. When in the brain, levodopa is decarboxylated to dopamine and stimulates
the dopaminergic receptors, thereby compensating for the depleted supply of endogenous
dopamine seen in Parkinson's disease. To assure that adequate concentrations of levodopa
reach the central nervous system, it is administered with carbidopa, a decarboxylase
inhibitor that does not cross the blood-brain barrier, thereby diminishing the decarboxylation
and inactivation of levodopa in peripheral tissues and increasing the delivery of
dopamine to the CNS.;
UNII : 46627O600J;
InChIKey : WTDRDQBEARUVNC-LURJTMIESA-N;
CAS number : 59-92-7;
Drug name : Dopaflex; Levopa; Eldopal; Maipedopa; Ledopa; Eurodopa; Laradopa; Eldopar; Dopalina; Dopal; Bendopa; Eldopatec; Cidandopa; Deadopa; Dopasol; Dopar; Doparkine; Doparl; Veldopa; Dopaston; Parda; Dopastral; Larodopa; Dopaidan; Doprin;
Chemical formula : C9H11NO4;
NSC code : 118381;
ChEBI ID : CHEBI:15765;
Codes from synonyms : NSC0118381;
Origin ID : C611;
UMLS CUI : C0023570;
Automatic exact mappings (from CISMeF team)
Currated CISMeF NLP mapping
See also inter- (CISMeF)
Semantic type(s)
UMLS correspondences (same concept)
Validated automatic mappings to BTNT
concept_is_in_subset